BioAge Labs (BIOA) Revenue & Revenue Breakdown
BioAge Labs Revenue Highlights
Latest Revenue (Y)
$8.99M
Latest Revenue (Q)
$2.77M
BioAge Labs Revenue by Period
BioAge Labs Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $8.99M | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2017-12-31 | $14.94M | 80.63% |
| 2016-12-31 | $8.27M | 280.88% |
| 2015-12-31 | $2.17M | 40.76% |
| 2014-12-31 | $1.54M | -42.10% |
| 2013-12-31 | $2.67M | - |
BioAge Labs generated $8.99M in revenue during NA 2025, up 100.00% compared to the previous quarter, and up 108.73% compared to the same period a year ago.
BioAge Labs Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $2.77M | -9.94% |
| 2025-12-31 | $3.08M | 49.85% |
| 2025-09-30 | $2.05M | -14.84% |
| 2025-06-30 | $2.41M | 66.23% |
| 2025-03-31 | $1.45M | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2017-12-31 | $5.40M | 63.47% |
| 2017-09-30 | $3.30M | -19.92% |
| 2017-06-30 | $4.12M | 94.13% |
| 2017-03-31 | $2.12M | 236.28% |
| 2016-12-31 | $631.46K | -82.75% |
| 2016-09-30 | $3.66M | 45.23% |
| 2016-06-30 | $2.52M | 72.86% |
| 2016-03-31 | $1.46M | 31.26% |
| 2015-12-31 | $1.11M | 215.93% |
| 2015-09-30 | $351.69K | 2.86% |
| 2015-06-30 | $341.90K | -6.90% |
| 2015-03-31 | $367.25K | 19.05% |
| 2014-12-31 | $308.48K | -34.27% |
| 2014-09-30 | $469.31K | 13.20% |
| 2014-06-30 | $414.60K | 18.23% |
| 2014-03-31 | $350.66K | -20.23% |
| 2013-12-31 | $439.60K | -49.27% |
| 2013-09-30 | $866.53K | -15.74% |
| 2013-06-30 | $1.03M | 210.95% |
| 2013-03-31 | $330.72K | - |
BioAge Labs generated $2.77M in revenue during Q1 2026, up -9.94% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
BioAge Labs Revenue Breakdown
BioAge Labs Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Sep 25 | Jun 25 | Mar 25 |
|---|---|---|---|
| Operating Segments | $2.05M | $2.41M | $1.45M |
Latest
BioAge Labs's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Operating Segments (100.00%).
BioAge Labs Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| OMI | Owens & Minor | $2.76B | $627.78M |
| CGC | Canopy Growth | $297.15M | $90.39M |
| ACB | Aurora Cannabis | $233.29M | $64.42M |
| LFCR | Lifecore Biomedical | $128.26M | $31.11M |
| TKNO | Alpha Teknova | $40.52M | $11.08M |
| BIOA | BioAge Labs | $8.99M | $2.77M |
| HUMA | Humacyte | $2.04M | $753.00K |
| EDIT | Editas Medicine | - | - |
| CABA | Cabaletta Bio | - | - |
| ALLO | Allogene Therapeutics | - | - |
| AVIR | Atea Pharmaceuticals | - | - |